Market Closed -
OTC Markets
09:39:47 2024-05-15 EDT
|
5-day change
|
1st Jan Change
|
0.135
USD
|
-13.16%
|
|
-8.91%
|
+58.82%
|
Fiscal Period: August |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
131.6
|
85.93
|
42.88
|
22.78
|
Enterprise Value (EV)
2 |
133.5
|
89.24
|
47.86
|
28.43
|
P/E ratio
|
-18.9
x
|
-7.44
x
|
-2.73
x
|
-2.13
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
6,864,554,002
x
|
258,944,014
x
|
315,974,062
x
|
EV / Revenue
|
-
|
7,129,218,645
x
|
289,040,315
x
|
394,366,816
x
|
EV / EBITDA
|
-42,208,405
x
|
-13,826,016
x
|
-3,359,576
x
|
-2,985,098
x
|
EV / FCF
|
-53,761,791
x
|
-42,626,782
x
|
-103,996,836
x
|
-19,115,635
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
35.6
x
|
-88
x
|
-33.7
x
|
-3.47
x
|
Nbr of stocks (in thousands)
|
84,891
|
80,309
|
93,218
|
96,938
|
Reference price
3 |
1.550
|
1.070
|
0.4600
|
0.2350
|
Announcement Date
|
20-12-16
|
21-12-14
|
22-12-14
|
23-12-14
|
1USD in Million2CAD in Million3USD Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
0.0125
|
0.1656
|
0.0721
|
EBITDA
|
-
|
-3.163
|
-6.455
|
-14.25
|
-9.525
|
EBIT
1 |
-1.479
|
-3.629
|
-7.002
|
-14.31
|
-9.638
|
Operating Margin
|
-
|
-
|
-55,937.32%
|
-8,639.03%
|
-13,367.87%
|
Earnings before Tax (EBT)
1 |
-1.725
|
-6.608
|
-11.49
|
-15.54
|
-10.68
|
Net income
1 |
-1.725
|
-6.608
|
-11.49
|
-15.54
|
-10.68
|
Net margin
|
-
|
-
|
-91,749.85%
|
-9,383.59%
|
-14,807.58%
|
EPS
2 |
-0.0328
|
-0.0818
|
-0.1438
|
-0.1687
|
-0.1103
|
Free Cash Flow
|
-
|
-2.483
|
-2.094
|
-0.4602
|
-1.487
|
FCF margin
|
-
|
-
|
-16,724.74%
|
-277.93%
|
-2,063.06%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-12-04
|
20-12-16
|
21-12-14
|
22-12-14
|
23-12-14
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
4.67
|
1.91
|
3.31
|
4.98
|
5.65
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.6039
x
|
-0.5133
x
|
-0.3498
x
|
-0.5934
x
|
Free Cash Flow
|
-
|
-2.48
|
-2.09
|
-0.46
|
-1.49
|
ROE (net income / shareholders' equity)
|
-
|
-399%
|
-840%
|
1,379%
|
261%
|
ROA (Net income/ Total Assets)
|
-
|
-39.5%
|
-74.6%
|
-172%
|
-153%
|
Assets
1 |
-
|
16.73
|
15.4
|
9.057
|
6.959
|
Book Value Per Share
2 |
-0.0100
|
0.0400
|
-0.0100
|
-0.0100
|
-0.0700
|
Cash Flow per Share
2 |
0.0200
|
0
|
0.0100
|
0
|
0
|
Capex
|
-
|
1.83
|
0.22
|
1.19
|
0.08
|
Capex / Sales
|
-
|
-
|
1,788.26%
|
720.58%
|
115.36%
|
Announcement Date
|
19-12-04
|
20-12-16
|
21-12-14
|
22-12-14
|
23-12-14
|
|
1st Jan change
|
Capi.
|
---|
| +58.82% | 16.64M | | +45.15% | 6.34B | | -14.00% | 4.61B | | +9.54% | 3.39B | | -8.99% | 3.29B | | +50.03% | 2.02B | | -6.97% | 1.73B | | -0.31% | 1.67B | | +50.00% | 1.63B | | -10.61% | 1.59B |
Alternative Medicine
|